Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1991 Dec;96:53–56. doi: 10.1289/ehp.919653

Characteristics of the U.S. EPA's Office of Pesticide Programs' toxicity information databases.

K L Dearfield 1, J A Quest 1, R J Whiting 1, H F Stack 1, M D Waters 1
PMCID: PMC1568258  PMID: 1820278

Abstract

The United States Environmental Protection Agency's Office of Pesticide Programs (OPP) requires that data from toxicity testing be submitted to the OPP to support the registration of pesticide chemicals. Once the toxicity data are submitted, they are entered into various toxicity databases. The studies are listed in an archival database to catalog and allow retrieval of the study for review. Reviews of toxicity studies are then placed into a separate database that can be retrieved to support a regulatory position. Toxicity information for health effects other than cancer and gene mutations from chronic exposure is reviewed through a reference dose (RfD) approach, and these decisions and supporting data are entered into an RfD database. Carcinogenicity data are reviewed by a peer review process, and these decisions are entered into a newly developed database to show the regulatory decision with supporting data. The mutagenicity data are reviewed and acceptable data are entered into the Genetic Activity Profile system to catalog and display the submitted information. These databases contain the information used for hazard evaluations as part of the OPP review of pesticide chemicals.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashby J., Tennant R. W. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res. 1988 Jan;204(1):17–115. doi: 10.1016/0165-1218(88)90114-0. [DOI] [PubMed] [Google Scholar]
  2. Barnes D. G., Dourson M. Reference dose (RfD): description and use in health risk assessments. Regul Toxicol Pharmacol. 1988 Dec;8(4):471–486. doi: 10.1016/0273-2300(88)90047-5. [DOI] [PubMed] [Google Scholar]
  3. Waters M. D., Stack H. F., Brady A. L., Lohman P. H., Haroun L., Vainio H. Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds. Mutat Res. 1988 May-Aug;205(1-4):295–312. doi: 10.1016/0165-1218(88)90024-9. [DOI] [PubMed] [Google Scholar]
  4. Waters M. D., Stack H. F., Rabinowitz J. R., Garrett N. E. Genetic activity profiles and pattern recognition in test battery selection. Mutat Res. 1988 May-Aug;205(1-4):119–138. doi: 10.1016/0165-1218(88)90015-8. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES